Teachers Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $78.1M | Buy |
879,474
+49,662
| +6% | +$4.41M | 0.1% | 225 |
|
|
2018
Q4 | $70.7M | Buy |
829,812
+49,909
| +6% | +$4.25M | 0.1% | 213 |
|
|
2018
Q3 | $75.6M | Buy |
779,903
+126,415
| +19% | +$12.3M | 0.09% | 241 |
|
|
2018
Q2 | $61.6M | Buy |
653,488
+1,633
| +0.3% | +$154K | 0.08% | 295 |
|
|
2018
Q1 | $52.8M | Sell |
651,855
-250,009
| -28% | -$20.3M | 0.07% | 333 |
|
|
2017
Q4 | $80.4M | Sell |
901,864
-65,790
| -7% | -$5.87M | 0.1% | 223 |
|
|
2017
Q3 | $90.1M | Sell |
967,654
-5,637
| -0.6% | -$525K | 0.12% | 190 |
|
|
2017
Q2 | $88.4M | Buy |
973,291
+286,249
| +42% | +$26M | 0.12% | 194 |
|
|
2017
Q1 | $60.3M | Buy |
687,042
+123,833
| +22% | +$10.9M | 0.09% | 294 |
|
|
2016
Q4 | $46.7M | Sell |
563,209
-47,975
| -8% | -$3.97M | 0.07% | 320 |
|
|
2016
Q3 | $56.5M | Buy |
611,184
+91,069
| +18% | +$8.43M | 0.09% | 267 |
|
|
2016
Q2 | $40.5M | Sell |
520,115
-35,204
| -6% | -$2.74M | 0.07% | 335 |
|
|
2016
Q1 | $45.8M | Buy |
555,319
+10,306
| +2% | +$850K | 0.08% | 296 |
|
|
2015
Q4 | $57.1M | Buy |
545,013
+111,056
| +26% | +$11.6M | 0.11% | 239 |
|
|
2015
Q3 | $45.7M | Sell |
433,957
-219,505
| -34% | -$23.1M | 0.09% | 278 |
|
|
2015
Q2 | $89.4M | Buy |
653,462
+50,185
| +8% | +$6.86M | 0.17% | 126 |
|
|
2015
Q1 | $75.2M | Buy |
603,277
+88,291
| +17% | +$11M | 0.14% | 179 |
|
|
2014
Q4 | $46.6M | Buy |
514,986
+200,673
| +64% | +$18.1M | 0.09% | 298 |
|
|
2014
Q3 | $22.7M | Buy |
314,313
+222,032
| +241% | +$16M | 0.05% | 487 |
|
|
2014
Q2 | $5.74M | Buy |
92,281
+6,767
| +8% | +$421K | 0.01% | 1087 |
|
|
2014
Q1 | $5.83M | Buy |
85,514
+2,192
| +3% | +$150K | 0.01% | 1042 |
|
|
2013
Q4 | $5.86M | Sell |
83,322
-232,950
| -74% | -$16.4M | 0.01% | 1028 |
|
|
2013
Q3 | $22.8M | Sell |
316,272
-147,108
| -32% | -$10.6M | 0.06% | 447 |
|
|
2013
Q2 | $25.9M | Buy |
+463,380
| New | +$25.9M | 0.07% | 364 |
|